References
Stromnes, I. M. et al. T cells engineered against a native antigen can surmount immunologic and physical barriers to treat pancreatic ductal adenocarcinoma. Cancer Cell 28, 638–652 (2015)
Rights and permissions
About this article
Cite this article
Flemming, A. Engineered T cells gain access to pancreatic tumours. Nat Rev Drug Discov 15, 16–17 (2016). https://doi.org/10.1038/nrd.2015.40
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd.2015.40
- Springer Nature Limited